In the evolving landscape of diabetes management, novel therapies like semaglutide and retatrutide are gaining traction. These drugs, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family, offer https://marcfnny358793.sharebyblog.com/38946301/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management